Letter to healthcare professionals: Important information on the potential risk of genotoxicity with the use of the medicinal product CONTROLFLEX

09.12.2021 2099 views

Лист-звернення до медичних працівників: Важлива інформація щодо потенційного ризику генотоксичності при застосуванні лікарського засобу КОНТРОЛФЛЕКСPDF · 97 КБ

Завантажити

Letter to healthcare professionals: Important information on the potential risk of genotoxicity with the use of the medicinal product CONTROLFLEX

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Letter to healthcare professionals: Important information on the potential risk of genotoxicity with the use of the medicinal product CONTROLFLEX

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration